(Q55072950)

English

LRRK2-G2019S mutation is not associated with an increased cancer risk: a kin-cohort study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

http://europepmc.org/abstract/MED/25048644

LRRK2-G2019S mutation is not associated with an increased cancer risk: a kin-cohort study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

http://europepmc.org/abstract/MED/25048644

Stefano Goldwurm

5

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

http://europepmc.org/abstract/MED/25048644

4

object named as

Gianni Pezzoli

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

author name string

Roberta Allegra

1

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

http://europepmc.org/abstract/MED/25048644

Sara Tunesi

2

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

http://europepmc.org/abstract/MED/25048644

Roberto Cilia

3

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

http://europepmc.org/abstract/MED/25048644

language of work or name

0 references

publication date

22 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

http://europepmc.org/abstract/MED/25048644

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

http://europepmc.org/abstract/MED/25048644

29

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

http://europepmc.org/abstract/MED/25048644

10

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

http://europepmc.org/abstract/MED/25048644

1325-1326

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

http://europepmc.org/abstract/MED/25048644

Deciphering the function of leucine-rich repeat kinase 2 and targeting its dysfunction in disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25969

21 January 2018

LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25969

21 January 2018

The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25969

21 January 2018

Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25969

21 January 2018

Kin-cohort analysis of LRRK2-G2019S penetrance in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25969

21 January 2018

LRRK2 mutations in Parkinson's disease: confirmation of a gender effect in the Italian population

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25969

21 January 2018

Identifiers

10.1002/MDS.25969

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

http://europepmc.org/abstract/MED/25048644

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2018

http://europepmc.org/abstract/MED/25048644

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55072950&oldid=1005470389"